<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02432456</url>
  </required_header>
  <id_info>
    <org_study_id>PRO00024679</org_study_id>
    <nct_id>NCT02432456</nct_id>
  </id_info>
  <brief_title>Ketamine Infusion Therapy for the Management of Acute Pain in Adult Rib Fracture Patients</brief_title>
  <official_title>Ketamine Infusion Therapy for the Management of Acute Pain in Adult Rib Fracture Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical College of Wisconsin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical College of Wisconsin</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the effectiveness of ketamine infusions in the management of acute
      pain resulting from broken ribs suffered following a blunt trauma. Half of patients will
      receive the institutional standard of care and a placebo infusion (no active medication). The
      other half of patients will receive the institutional standard of care and a ketamine
      infusion. All subjects and staff will be blinded as to whether they are receiving placebo or
      ketamine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A prospective randomized, double blinded trial of ketamine use in adult and elderly blunt
      trauma patients with associated rib fractures admitted to the trauma service will be
      conducted. Examples of blunt mechanisms include assault, falls, motor vehicle collisions,
      motorcycle crashes, motor vehicle pedestrian collisions, crush injuries, and bicycle
      accidents. The experimental arm of the trial will receive ketamine infusion therapy while the
      control arm receives saline placebo infusions at an equivalent rate. All patients will be
      managed with adjunct therapy including opiates in accordance with the institutional thoracic
      trauma protocols. Two separate trials based on patient age are included in this study.
      Elderly rib fracture patients are certainly of interest but will be evaluated as a distinct
      entity given the discrete differences in the complications of rib fractures and the goals of
      therapy.

      All blunt trauma patients with associated rib fractures will be screened. All patients will
      be enrolled into the institutional standard thoracic trauma pathway. All individuals will
      undergo Intercostal Nerve Block (ICNB) in the Emergency Department or on admission to the
      Intensive Care Unit. In addition to scheduled medications per institutional thoracic trauma
      protocols, all patients will receive adjunct opiate therapy. Patients will be screened by the
      clinical and pharmacy staff following the diagnosis of rib fractures for eligibility.
      Patients enrolled into the trial will be randomized into either the experimental or control
      arm of the trial. The Investigational Drug Services (IDS) department will randomize all
      enrollees and handle administration of all trial drugs. The infusate will be mixed by the IDS
      department and all bags will be labeled &quot;Ketamine / Placebo.&quot; The IDS department will have
      unique bag identifiers, which will allow them to identify which bags have active ketamine and
      which are placebo in case of emergency.

      Patients will be randomized in a 1:1 fashion for experimental and control arms. Those
      enrolled in the experimental arm will receive early ketamine infusion therapy at a fixed
      infusion rate. For those enrolled in the adult trial the infusion rate will be 2.5 mcg/kg/min
      while those in the elderly trial will receive infusions at 2.0 mcg/kg/min. All ketamine
      infusions will be calculated based on ideal body weight (IBW), unless actual body weight is
      less than ideal. IBW will be calculated for males as 50kg + 2.3*(number of inches above 5
      feet) and for women as 45.5kg + 2.3*(number of inches over 5 feet). Patients randomized to
      the control arm will receive placebo saline solution at an equivalent rate. Time zero will be
      defined as the time at which the &quot;ketamine / placebo&quot; infusion is begun. For inclusion in the
      trial, initiation of ketamine / placebo infusions must take place within 6 hours of
      presentation to Froedtert Memorial Lutheran Hospital (FMLH). Ketamine infusion therapy will
      be continued for 48 hours. At 6-8 hours post-ICNB all subjects will be assessed for need for
      repeat ICNB. Need for repeat ICNB will be defined by a thoracic specific numeric pain score
      greater than seven. Between eight and ten hours post-ketamine infusion initiation, subjects
      who have thoracic specific pain scores above seven will be evaluated for epidural placement
      by the Regional Anesthesia and Acute Pain Service.

      A subject will be allowed to remove himself/herself from the trial or be un-blinded should
      he/she, pharmacy, anesthesia, and/or surgical staff deem it medically necessary. Medical
      necessity would be determined by inability to treat the patient appropriately without
      knowledge of trial assignment; otherwise the assumption of treating staff will be all
      patients have received ketamine. All adverse events will be recorded and if necessary
      subjects will be un-blinded in the event of a serious adverse event. The trauma and
      anesthesia teams along with the inpatient clinical pharmacists will monitor all trial
      patients for any adverse event trends. Patients will be followed through the time of
      discharge.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Actual">August 2018</completion_date>
  <primary_completion_date type="Actual">August 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analog Numeric Pain Score</measure>
    <time_frame>12-24 hours post infusion</time_frame>
    <description>Visual Analog Numeric Pain scores are reported as a single numeric score between 0 and 10. The more severe the pain the higher the number with 10 representing the most severe pain imaginable.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual Analog Numeric Pain Score</measure>
    <time_frame>24-48 hours post infusion</time_frame>
    <description>Visual Analog Numeric Pain scores are reported as a single numeric score between 0 and 10. The more severe the pain the higher the number with 10 representing the most severe pain imaginable.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oral Morphine Equivalent (Narcotic Usage)</measure>
    <time_frame>12-24 hours post infusion</time_frame>
    <description>This is an analysis of the narcotic utilization during the study. Oral Morphine Equivalents is a means of standardizing narcotic utilization given a multitude of different medications are utilized. Medications are standardized to units (milligrams) or oral morphine for a standardized comparison.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oral Morphine Equivalent (Narcotic Usage)</measure>
    <time_frame>24-48 hours post infusion</time_frame>
    <description>This is an analysis of the narcotic utilization during the study. Oral Morphine Equivalents is a means of standardizing narcotic utilization given a multitude of different medications are utilized. Medications are standardized to units (milligrams) or oral morphine for a standardized comparison.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of Stay</measure>
    <time_frame>Total Index Hospitalization up to 365 days</time_frame>
    <description>Total hospital length of stay in days up to 365 days.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Regional Anesthesia Utilization</measure>
    <time_frame>Total Index Hospitalization up to 365 days</time_frame>
    <description>This is a measure of the Epidural Placement rates. Epidural placement was binary as in patient received or did not receive an epidural infusion catheter for supplemental pain management.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Failure</measure>
    <time_frame>Total Index Hospitalization up to 365 days</time_frame>
    <description>Respiratory failure within this trial was defined by the need for unanticipated intubation and/or transfer to ICU for respiratory support.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hallucination</measure>
    <time_frame>Total Index Hospitalization up to 365 days</time_frame>
    <description>Hallucinations were documented and confirmed by the treating medical team.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oral Morphine Equivalent (Narcotic Usage) in Severely Injured</measure>
    <time_frame>Total Index Hospitalization up to 365 days</time_frame>
    <description>This is an analysis of the narcotic utilization during the study. Oral Morphine Equivalents is a means of standardizing narcotic utilization given a multitude of different medications are utilized. Medications are standardized to units (milligrams) or oral morphine for a standardized comparison.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">153</enrollment>
  <condition>Wounds and Injuries</condition>
  <condition>Rib Fractures</condition>
  <arm_group>
    <arm_group_label>Placebo Infusion</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects in this arm will receive the institutional standard of care for rib fractures along with a placebo (NaCl) infusion.
All patients will undergo Intercostal Nerve Blockade with administration of scheduled medications including acetaminophen, ibuprofen, pantoprazole, and methocarbamol. All subjects will receive adjunct opioids.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ketamine Infusion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects in this arm will receive the institutional standard of care for rib fractures along with a ketamine infusion.
All patients will undergo Intercostal Nerve Blockade with administration of scheduled medications including acetaminophen, ibuprofen, pantoprazole, and methocarbamol. All subjects will receive adjunct opioids.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>All individuals randomized to the experimental arm of the trial will receive early ketamine therapy (within 6 hours of admission) at a rate of 0.15 mg/kg/hr dosed based on ideal body weight. Individuals in the control arm will receive our standard of care for thoracic trauma patients, however, they will receive an additional placebo infusion of normal saline.</description>
    <arm_group_label>Ketamine Infusion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Individuals enrolled into the control arm of the trial will receive a normal saline placebo infusion at a rate equivalent to the dosage of ketamine in the experimental arm.</description>
    <arm_group_label>Placebo Infusion</arm_group_label>
    <other_name>NaCl Placebo Solution</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Intercostal Nerve Block</intervention_name>
    <description>All individuals enrolled into the trial will undergo an Intercostal Nerve Blockade as a part of the institutional standard of care for rib fractures. This procedure will be performed according to current standard protocols in the Emergency Department or on admission.</description>
    <arm_group_label>Ketamine Infusion</arm_group_label>
    <arm_group_label>Placebo Infusion</arm_group_label>
    <other_name>Rib Block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetaminophen</intervention_name>
    <description>All patients admitted to the hospital will be placed on scheduled acetaminophen 1000mg PO q 6 hours unless signs of liver disease/impairment or creatinine clearance &lt; 35ml/min at which point dosage would be reduced to 650mg q 8 hours. Individuals unable to take oral medications would be placed on intravenous acetaminophen.</description>
    <arm_group_label>Ketamine Infusion</arm_group_label>
    <arm_group_label>Placebo Infusion</arm_group_label>
    <other_name>Tylenol</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ibuprofen</intervention_name>
    <description>All patients will be placed on scheduled Ibuprofen or an equivalent NSAID at dosage of 600mg every 6 hours. Patients must have a Glomerular Filtration Rate &gt; 60 ml/min with no contraindications to NSAID therapy (e.g. Aspirin use, allergy/sensitivity, concurrent ACE inhibitor use, other nephrotoxins, etc)</description>
    <arm_group_label>Ketamine Infusion</arm_group_label>
    <arm_group_label>Placebo Infusion</arm_group_label>
    <other_name>Advil, Motrin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pantoprazole</intervention_name>
    <description>All individuals on scheduled Non-Steroidal Anti-Inflammatory Drug (NSAID) therapy will receive scheduled pantoprazole at 40mg daily. Individuals unable to take medications orally will be placed on intravenous therapy. Individuals with previous reaction or intolerance to pantoprazole will be placed on an equivalent proton pump inhibitor.</description>
    <arm_group_label>Ketamine Infusion</arm_group_label>
    <arm_group_label>Placebo Infusion</arm_group_label>
    <other_name>Protonix</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methocarbamol</intervention_name>
    <description>All individuals enrolled in the trial will be placed on scheduled methocarbamol 500 mg orally every 6 hours while admitted. Individuals with previous intolerance to methocarbamol will be placed on a pharmacy directed equivalent.</description>
    <arm_group_label>Ketamine Infusion</arm_group_label>
    <arm_group_label>Placebo Infusion</arm_group_label>
    <other_name>Robaxin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Opioid</intervention_name>
    <description>All individuals will receive as needed opiate therapy as an adjunct to the scheduled medications and &quot;ketamine/placebo&quot; solution. Choice in opiate therapy will be at the discretion of the attending trauma faculty. Dosage and adjustments will be in accordance with the institutional policy on appropriate opiate dosage adjustment.</description>
    <arm_group_label>Ketamine Infusion</arm_group_label>
    <arm_group_label>Placebo Infusion</arm_group_label>
    <other_name>opiate, narcotic</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. age greater than 18 years

          2. rib fractures following recent trauma with admission to Froedtert Memorial Lutheran
             Hospital

        Exclusion Criteria:

          1. history of adverse reaction / intolerance to ketamine therapy

          2. elevated intracranial pressure

          3. ischemic heart disease defined as active acute coronary syndrome

          4. severe, poorly controlled hypertension (Systolic Blood Pressure &gt; 200 mmHg or
             Diastolic Blood Pressure &gt; 100 mmHg)

          5. current opiate agonist/antagonist therapy

          6. concurrent use of monoamine oxidase inhibitors (MAOIs)

          7. chronic pain or opioid tolerance defined as &gt; 3 weeks of &gt;30mg oral morphine
             equivalents per day

          8. current substance abuse with opiates (prescription and/or heroin) or ketamine

          9. Glasgow Coma Scale &lt;13

         10. Intubation on arrival or need for urgent intubation on arrival

         11. inability to delineate pain and/or appropriately communicate with staff

         12. history of psychosis

         13. three or more psychotropic medications

         14. active delirium

         15. glaucoma

         16. pregnancy

         17. prisoners
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thomas W Carver, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical College of Wisconsin</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Froedtert Memorial Lutheran Hospital</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>April 20, 2015</study_first_submitted>
  <study_first_submitted_qc>April 28, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 4, 2015</study_first_posted>
  <results_first_submitted>December 15, 2019</results_first_submitted>
  <results_first_submitted_qc>January 27, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">February 5, 2020</results_first_posted>
  <last_update_submitted>January 27, 2020</last_update_submitted>
  <last_update_submitted_qc>January 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical College of Wisconsin</investigator_affiliation>
    <investigator_full_name>Nathan Kugler</investigator_full_name>
    <investigator_title>Lead Research Resident</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Pain</mesh_term>
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Rib Fractures</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Ibuprofen</mesh_term>
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Narcotics</mesh_term>
    <mesh_term>Methocarbamol</mesh_term>
    <mesh_term>Pantoprazole</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>February 1, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/56/NCT02432456/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Adult Study: From August 2015 to December of 2017, all adult blunt trauma patients with three or more rib fractures were screened for eligibility in this study.
Elderly Study: From August 2015 to June 2018, all elderly blunt trauma patients with three or more rib fractures were screened for eligibility in the study.</recruitment_details>
      <pre_assignment_details>153 patients agreed to participate. Three subjects (two from elderly and one from adult) were randomized but withdrawn prior to collecting any data or initiation of the infusions. This left a total of 150 participants within the trial, of which 75 were randomized to the placebo infusion with the other 75 randomized to the ketamine infusion.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Placebo Infusion</title>
          <description>Subjects in this arm received the institutional standard of care for rib fractures along with a placebo (NaCl) infusion.</description>
        </group>
        <group group_id="P2">
          <title>Ketamine Infusion</title>
          <description>Subjects in this arm will receive the institutional standard of care for rib fractures along with a ketamine infusion at a rate of 2.5 mcg/kg/min dosed based on ideal body weight.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="75"/>
                <participants group_id="P2" count="75"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="75"/>
                <participants group_id="P2" count="75"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Placebo Infusion</title>
          <description>Subjects in this arm received the institutional standard of care for rib fractures along with a placebo (NaCl) infusion.</description>
        </group>
        <group group_id="B2">
          <title>Ketamine Infusion</title>
          <description>Subjects in this arm will receive the institutional standard of care for rib fractures along with a ketamine infusion at a rate of 2.5 mcg/kg/min dosed based on ideal body weight.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="75"/>
            <count group_id="B2" value="75"/>
            <count group_id="B3" value="150"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="75"/>
                    <count group_id="B2" value="75"/>
                    <count group_id="B3" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="46"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="91"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="75"/>
                    <count group_id="B2" value="75"/>
                    <count group_id="B3" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="47"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="54"/>
                    <measurement group_id="B2" value="49"/>
                    <measurement group_id="B3" value="103"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="75"/>
                    <count group_id="B2" value="75"/>
                    <count group_id="B3" value="150"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="75"/>
                    <measurement group_id="B2" value="75"/>
                    <measurement group_id="B3" value="150"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI</title>
          <population>Adult trial consisted of 91 participants. The elderly trial consisted of 59 participants.</population>
          <units>kg/m^2</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <title>Adult BMI</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="46"/>
                    <count group_id="B2" value="45"/>
                    <count group_id="B3" value="91"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.5" lower_limit="18.7" upper_limit="50"/>
                    <measurement group_id="B2" value="29" lower_limit="18.3" upper_limit="51.7"/>
                    <measurement group_id="B3" value="29" lower_limit="18.3" upper_limit="51.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elderly BMI</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="29"/>
                    <count group_id="B2" value="30"/>
                    <count group_id="B3" value="59"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26.8" lower_limit="20.6" upper_limit="39.7"/>
                    <measurement group_id="B2" value="29.2" lower_limit="22.5" upper_limit="38"/>
                    <measurement group_id="B3" value="27.7" lower_limit="20.6" upper_limit="39.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of Rib Fractures</title>
          <population>Adult trial consisted of 91 participants. The elderly trial consisted of 59 participants.</population>
          <units>Rib Fractures</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Adult</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="46"/>
                    <count group_id="B2" value="45"/>
                    <count group_id="B3" value="91"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6.4" spread="3.3"/>
                    <measurement group_id="B2" value="6.4" spread="3.2"/>
                    <measurement group_id="B3" value="6.4" spread="3.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elderly</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="29"/>
                    <count group_id="B2" value="30"/>
                    <count group_id="B3" value="59"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6.5" spread="3.4"/>
                    <measurement group_id="B2" value="6.1" spread="2.6"/>
                    <measurement group_id="B3" value="6.3" spread="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Flail Chest</title>
          <population>Adult trial consisted of 91 participants. The elderly trial consisted of 59 participants.</population>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Adult</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="46"/>
                    <count group_id="B2" value="45"/>
                    <count group_id="B3" value="91"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elderly</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="29"/>
                    <count group_id="B2" value="30"/>
                    <count group_id="B3" value="59"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Injury Severity Score, median</title>
          <population>Injury severity of each of 6 body systems is scored according the Abbreviated Injury Scale. Three body systems with the highest AIS scores are used to calculate the Injury Severity Score (ISS). These scores are squared and the results summed to produce the Injury Severity Score which ranges from 3-75. The higher the ISS the greater the injury.</population>
          <units>Injury Severity Scale Score</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <title>Adult</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="46"/>
                    <count group_id="B2" value="45"/>
                    <count group_id="B3" value="91"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13" lower_limit="9" upper_limit="38"/>
                    <measurement group_id="B2" value="17" lower_limit="9" upper_limit="34"/>
                    <measurement group_id="B3" value="14" lower_limit="9" upper_limit="38"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elderly</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="29"/>
                    <count group_id="B2" value="30"/>
                    <count group_id="B3" value="59"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14" lower_limit="9" upper_limit="48"/>
                    <measurement group_id="B2" value="13" lower_limit="4" upper_limit="41"/>
                    <measurement group_id="B3" value="13" lower_limit="4" upper_limit="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Injury Severity Score greater than15</title>
          <population>Adult trial consisted of 91 participants. The elderly trial consisted of 59 participants.</population>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Adult</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="46"/>
                    <count group_id="B2" value="45"/>
                    <count group_id="B3" value="91"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elderly</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="29"/>
                    <count group_id="B2" value="30"/>
                    <count group_id="B3" value="59"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>ICU Admission</title>
          <population>Adult trial consisted of 91 participants. The elderly trial consisted of 59 participants.</population>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Adult</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="46"/>
                    <count group_id="B2" value="45"/>
                    <count group_id="B3" value="91"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elderly</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="29"/>
                    <count group_id="B2" value="30"/>
                    <count group_id="B3" value="59"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Motor Vehicle Collision</title>
          <population>Adult trial consisted of 91 participants. The elderly trial consisted of 59 participants.</population>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Adult</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="46"/>
                    <count group_id="B2" value="45"/>
                    <count group_id="B3" value="91"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elderly</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="29"/>
                    <count group_id="B2" value="30"/>
                    <count group_id="B3" value="59"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Fall</title>
          <population>Adult trial consisted of 91 participants. The elderly trial consisted of 59 participants.</population>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Adult</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="46"/>
                    <count group_id="B2" value="45"/>
                    <count group_id="B3" value="91"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elderly</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="29"/>
                    <count group_id="B2" value="30"/>
                    <count group_id="B3" value="59"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Other Mechanism of Injury</title>
          <population>Adult trial consisted of 91 participants. The elderly trial consisted of 59 participants.</population>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Adult</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="46"/>
                    <count group_id="B2" value="45"/>
                    <count group_id="B3" value="91"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elderly</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="29"/>
                    <count group_id="B2" value="30"/>
                    <count group_id="B3" value="59"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Visual Analog Numeric Pain Score</title>
        <description>Visual Analog Numeric Pain scores are reported as a single numeric score between 0 and 10. The more severe the pain the higher the number with 10 representing the most severe pain imaginable.</description>
        <time_frame>12-24 hours post infusion</time_frame>
        <population>Adult trial consisted of 91 participants. The elderly trial consisted of 59 participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo Infusion</title>
            <description>Subjects in this arm received the institutional standard of care for rib fractures along with a placebo (NaCl) infusion.</description>
          </group>
          <group group_id="O2">
            <title>Ketamine Infusion</title>
            <description>Subjects in this arm will receive the institutional standard of care for rib fractures along with a ketamine infusion at a rate of 2.5 mcg/kg/min dosed based on ideal body weight.</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Analog Numeric Pain Score</title>
          <description>Visual Analog Numeric Pain scores are reported as a single numeric score between 0 and 10. The more severe the pain the higher the number with 10 representing the most severe pain imaginable.</description>
          <population>Adult trial consisted of 91 participants. The elderly trial consisted of 59 participants.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Adult</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.1" spread="2"/>
                    <measurement group_id="O2" value="5.7" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elderly</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="29"/>
                    <count group_id="O2" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.2" spread="1.3"/>
                    <measurement group_id="O2" value="5.1" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Visual Analog Numeric Pain Score</title>
        <description>Visual Analog Numeric Pain scores are reported as a single numeric score between 0 and 10. The more severe the pain the higher the number with 10 representing the most severe pain imaginable.</description>
        <time_frame>24-48 hours post infusion</time_frame>
        <population>Adult trial consisted of 91 participants. The elderly trial consisted of 59 participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo Infusion</title>
            <description>Subjects in this arm received the institutional standard of care for rib fractures along with a placebo (NaCl) infusion.</description>
          </group>
          <group group_id="O2">
            <title>Ketamine Infusion</title>
            <description>Subjects in this arm will receive the institutional standard of care for rib fractures along with a ketamine infusion at a rate of 2.5 mcg/kg/min dosed based on ideal body weight.</description>
          </group>
        </group_list>
        <measure>
          <title>Visual Analog Numeric Pain Score</title>
          <description>Visual Analog Numeric Pain scores are reported as a single numeric score between 0 and 10. The more severe the pain the higher the number with 10 representing the most severe pain imaginable.</description>
          <population>Adult trial consisted of 91 participants. The elderly trial consisted of 59 participants.</population>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Adult</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.8" spread="1.9"/>
                    <measurement group_id="O2" value="5.6" spread="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elderly</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="29"/>
                    <count group_id="O2" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.4" spread="1.6"/>
                    <measurement group_id="O2" value="5.1" spread="1.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Oral Morphine Equivalent (Narcotic Usage)</title>
        <description>This is an analysis of the narcotic utilization during the study. Oral Morphine Equivalents is a means of standardizing narcotic utilization given a multitude of different medications are utilized. Medications are standardized to units (milligrams) or oral morphine for a standardized comparison.</description>
        <time_frame>12-24 hours post infusion</time_frame>
        <population>Adult trial consisted of 91 participants. The elderly trial consisted of 59 participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo Infusion</title>
            <description>Subjects in this arm received the institutional standard of care for rib fractures along with a placebo (NaCl) infusion.</description>
          </group>
          <group group_id="O2">
            <title>Ketamine Infusion</title>
            <description>Subjects in this arm will receive the institutional standard of care for rib fractures along with a ketamine infusion at a rate of 2.5 mcg/kg/min dosed based on ideal body weight.</description>
          </group>
        </group_list>
        <measure>
          <title>Oral Morphine Equivalent (Narcotic Usage)</title>
          <description>This is an analysis of the narcotic utilization during the study. Oral Morphine Equivalents is a means of standardizing narcotic utilization given a multitude of different medications are utilized. Medications are standardized to units (milligrams) or oral morphine for a standardized comparison.</description>
          <population>Adult trial consisted of 91 participants. The elderly trial consisted of 59 participants.</population>
          <units>oral morphine equivalents</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Adult</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="45.0" lower_limit="0" upper_limit="295"/>
                    <measurement group_id="O2" value="45" lower_limit="0" upper_limit="187.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elderly</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="29"/>
                    <count group_id="O2" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="30" lower_limit="0" upper_limit="131"/>
                    <measurement group_id="O2" value="21.3" lower_limit="0" upper_limit="203"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Oral Morphine Equivalent (Narcotic Usage)</title>
        <description>This is an analysis of the narcotic utilization during the study. Oral Morphine Equivalents is a means of standardizing narcotic utilization given a multitude of different medications are utilized. Medications are standardized to units (milligrams) or oral morphine for a standardized comparison.</description>
        <time_frame>24-48 hours post infusion</time_frame>
        <population>Adult trial consisted of 91 participants. The elderly trial consisted of 59 participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo Infusion</title>
            <description>Subjects in this arm received the institutional standard of care for rib fractures along with a placebo (NaCl) infusion.</description>
          </group>
          <group group_id="O2">
            <title>Ketamine Infusion</title>
            <description>Subjects in this arm will receive the institutional standard of care for rib fractures along with a ketamine infusion at a rate of 2.5 mcg/kg/min dosed based on ideal body weight.</description>
          </group>
        </group_list>
        <measure>
          <title>Oral Morphine Equivalent (Narcotic Usage)</title>
          <description>This is an analysis of the narcotic utilization during the study. Oral Morphine Equivalents is a means of standardizing narcotic utilization given a multitude of different medications are utilized. Medications are standardized to units (milligrams) or oral morphine for a standardized comparison.</description>
          <population>Adult trial consisted of 91 participants. The elderly trial consisted of 59 participants.</population>
          <units>oral morphine equivalents</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Adult</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67" lower_limit="0" upper_limit="1201.0"/>
                    <measurement group_id="O2" value="69.0" lower_limit="0" upper_limit="656.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elderly</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="29"/>
                    <count group_id="O2" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="44" lower_limit="0" upper_limit="302"/>
                    <measurement group_id="O2" value="25" lower_limit="0" upper_limit="765"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Length of Stay</title>
        <description>Total hospital length of stay in days up to 365 days.</description>
        <time_frame>Total Index Hospitalization up to 365 days</time_frame>
        <population>Adult trial consisted of 91 participants. The elderly trial consisted of 59 participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo Infusion</title>
            <description>Subjects in this arm received the institutional standard of care for rib fractures along with a placebo (NaCl) infusion.</description>
          </group>
          <group group_id="O2">
            <title>Ketamine Infusion</title>
            <description>Subjects in this arm will receive the institutional standard of care for rib fractures along with a ketamine infusion at a rate of 2.5 mcg/kg/min dosed based on ideal body weight.</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Stay</title>
          <description>Total hospital length of stay in days up to 365 days.</description>
          <population>Adult trial consisted of 91 participants. The elderly trial consisted of 59 participants.</population>
          <units>days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Adult</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.0" lower_limit="1" upper_limit="33"/>
                    <measurement group_id="O2" value="5" lower_limit="1" upper_limit="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elderly</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="29"/>
                    <count group_id="O2" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6" lower_limit="2" upper_limit="109"/>
                    <measurement group_id="O2" value="5" lower_limit="2" upper_limit="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Regional Anesthesia Utilization</title>
        <description>This is a measure of the Epidural Placement rates. Epidural placement was binary as in patient received or did not receive an epidural infusion catheter for supplemental pain management.</description>
        <time_frame>Total Index Hospitalization up to 365 days</time_frame>
        <population>Adult trial consisted of 91 participants. The elderly trial consisted of 59 participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo Infusion</title>
            <description>Subjects in this arm received the institutional standard of care for rib fractures along with a placebo (NaCl) infusion.</description>
          </group>
          <group group_id="O2">
            <title>Ketamine Infusion</title>
            <description>Subjects in this arm will receive the institutional standard of care for rib fractures along with a ketamine infusion at a rate of 2.5 mcg/kg/min dosed based on ideal body weight.</description>
          </group>
        </group_list>
        <measure>
          <title>Regional Anesthesia Utilization</title>
          <description>This is a measure of the Epidural Placement rates. Epidural placement was binary as in patient received or did not receive an epidural infusion catheter for supplemental pain management.</description>
          <population>Adult trial consisted of 91 participants. The elderly trial consisted of 59 participants.</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Adult</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elderly</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="29"/>
                    <count group_id="O2" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Respiratory Failure</title>
        <description>Respiratory failure within this trial was defined by the need for unanticipated intubation and/or transfer to ICU for respiratory support.</description>
        <time_frame>Total Index Hospitalization up to 365 days</time_frame>
        <population>Adult trial consisted of 91 participants. The elderly trial consisted of 59 participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo Infusion</title>
            <description>Subjects in this arm received the institutional standard of care for rib fractures along with a placebo (NaCl) infusion.</description>
          </group>
          <group group_id="O2">
            <title>Ketamine Infusion</title>
            <description>Subjects in this arm will receive the institutional standard of care for rib fractures along with a ketamine infusion at a rate of 2.5 mcg/kg/min dosed based on ideal body weight.</description>
          </group>
        </group_list>
        <measure>
          <title>Respiratory Failure</title>
          <description>Respiratory failure within this trial was defined by the need for unanticipated intubation and/or transfer to ICU for respiratory support.</description>
          <population>Adult trial consisted of 91 participants. The elderly trial consisted of 59 participants.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Adult</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elderly</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="29"/>
                    <count group_id="O2" value="31"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hallucination</title>
        <description>Hallucinations were documented and confirmed by the treating medical team.</description>
        <time_frame>Total Index Hospitalization up to 365 days</time_frame>
        <population>Adult trial consisted of 91 participants. The elderly trial consisted of 59 participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo Infusion</title>
            <description>Subjects in this arm received the institutional standard of care for rib fractures along with a placebo (NaCl) infusion.</description>
          </group>
          <group group_id="O2">
            <title>Ketamine Infusion</title>
            <description>Subjects in this arm will receive the institutional standard of care for rib fractures along with a ketamine infusion at a rate of 2.5 mcg/kg/min dosed based on ideal body weight.</description>
          </group>
        </group_list>
        <measure>
          <title>Hallucination</title>
          <description>Hallucinations were documented and confirmed by the treating medical team.</description>
          <population>Adult trial consisted of 91 participants. The elderly trial consisted of 59 participants.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="75"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Adult</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="46"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elderly</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="29"/>
                    <count group_id="O2" value="30"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Oral Morphine Equivalent (Narcotic Usage) in Severely Injured</title>
        <description>This is an analysis of the narcotic utilization during the study. Oral Morphine Equivalents is a means of standardizing narcotic utilization given a multitude of different medications are utilized. Medications are standardized to units (milligrams) or oral morphine for a standardized comparison.</description>
        <time_frame>Total Index Hospitalization up to 365 days</time_frame>
        <population>A total of 45 participants were categorized as severely injured within the adult trial. A total of 24 participants were categorized as severely injured within the elderly trial.</population>
        <group_list>
          <group group_id="O1">
            <title>Placebo Infusion</title>
            <description>Subjects in this arm received the institutional standard of care for rib fractures along with a placebo (NaCl) infusion.</description>
          </group>
          <group group_id="O2">
            <title>Ketamine Infusion</title>
            <description>Subjects in this arm will receive the institutional standard of care for rib fractures along with a ketamine infusion at a rate of 2.5 mcg/kg/min dosed based on ideal body weight.</description>
          </group>
        </group_list>
        <measure>
          <title>Oral Morphine Equivalent (Narcotic Usage) in Severely Injured</title>
          <description>This is an analysis of the narcotic utilization during the study. Oral Morphine Equivalents is a means of standardizing narcotic utilization given a multitude of different medications are utilized. Medications are standardized to units (milligrams) or oral morphine for a standardized comparison.</description>
          <population>A total of 45 participants were categorized as severely injured within the adult trial. A total of 24 participants were categorized as severely injured within the elderly trial.</population>
          <units>oral morphine equivalents</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Adult</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="19"/>
                    <count group_id="O2" value="26"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="170.5" lower_limit="0" upper_limit="1589.0"/>
                    <measurement group_id="O2" value="153.0" lower_limit="0" upper_limit="758.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elderly</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="14"/>
                    <count group_id="O2" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="86.8" lower_limit="0" upper_limit="376"/>
                    <measurement group_id="O2" value="67.5" lower_limit="0" upper_limit="988"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Data was collected for the duration of all participants hospitalizations. At time of discharge adverse event recording was stopped as patients were monitored throughout only their index stay defined up to 365 days.</time_frame>
      <desc>All adverse events were reported and reviewed by the IRB at our insitution.</desc>
      <group_list>
        <group group_id="E1">
          <title>Placebo Infusion</title>
          <description>Subjects in this arm received the institutional standard of care for rib fractures along with a placebo (NaCl) infusion.</description>
        </group>
        <group group_id="E2">
          <title>Ketamine Infusion</title>
          <description>Subjects in this arm will receive the institutional standard of care for rib fractures along with a ketamine infusion at a rate of 2.5 mcg/kg/min dosed based on ideal body weight.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="75"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="75"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="15" subjects_at_risk="75"/>
                <counts group_id="E2" subjects_affected="7" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Delirium</sub_title>
                <description>Delirium as outlined by positive CAM testing</description>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="75"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="75"/>
              </event>
              <event>
                <sub_title>Sedation</sub_title>
                <description>Concern on nursing that patient was sedated as result of over medication</description>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="75"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="75"/>
              </event>
              <event>
                <sub_title>Hallucinations</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="75"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Respiratory Failure</sub_title>
                <description>Need for intubation</description>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="75"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="75"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>NPS presents challenges as pain is subjective and difficult to assess. Treating providers were allowed any medications within the multimodal rib fracture pain protocol leading to non-standardized pain regimens based on providers.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Thomas Carver</name_or_title>
      <organization>Medical College of Wisconsin</organization>
      <phone>414-955-1733</phone>
      <email>tcarver@mcw.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

